The interaction of heparin/polyanions with bovine, porcine, and human growth hormone

Journal of Pharmaceutical Sciences

Volumn 97, Issue 4, 2008, Pages 1368-1385

  Joshi, Sangeeta B ^a   Kamerzell, Tim J ^a   McNown, Chris ^a   Middaugh, C Russell ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

Circular dichroism; Fluorescence; Growth hormone; Heparin; Isothermal titration calorimetry; Polyanion; Stability; Thermodynamics

Indexed keywords

DEXTRAN SULFATE; GROWTH HORMONE; HEPARIN; HUMAN GROWTH HORMONE; PHYTIC ACID; POLYANION; SODIUM CHLORIDE;

ARTICLE; BINDING AFFINITY; CATTLE; CIRCULAR DICHROISM; DRUG PROTEIN BINDING; FLUORESCENCE; HORMONE RECEPTOR INTERACTION; HYDRODYNAMICS; ISOTHERMAL TITRATION CALORIMETRY; LIGAND BINDING; LIGHT SCATTERING; MOLECULAR WEIGHT; PROTEIN BINDING; RED EDGE EXCITATION SPECTROSCOPY; SPECTROFLUOROMETRY; SPECTROSCOPY; STRUCTURE ANALYSIS; SWINE; THERMODYNAMICS; ANIMAL; CALORIMETRY; CHEMISTRY; HUMAN; LIGHT; RADIATION SCATTERING;

ANIMALS; CALORIMETRY; CATTLE; CIRCULAR DICHROISM; FLUORESCENCE; GROWTH HORMONE; HEPARIN; HUMAN GROWTH HORMONE; HUMANS; LIGHT; SCATTERING, RADIATION; SWINE; THERMODYNAMICS;

EID: 43249095250     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21056     Document Type: Article

References (45)

1. Nicoll CS, Mayer GL, Russell SM. 1986. Structural features of prolactins and growth hormones that can be related to their biological properties. Endocr Rev 7:169-203.
2. Carlacci L, Chou KC, Maggiora GM. 1991. A heuristic approach to predicting the tertiary structure of bovine somatotropin. Biochemistry 30:4389-4398.
3. Abdel-Meguid SS, Shieh HS, Smith WW, Dayringer HE, Violand BN, Bentle LA. 1987. Three-dimensional structure of a genetically engineered variant of porcine growth hormone. Proc Natl Acad Sci USA 84:6434-6437.
4. Ultsch MH, Somers W, Kossiakoff AA, de Vos AM. 1994. The crystal structure of affinity-matured human growth hormone at 2 A resolution. J Mol Biol 236:286-299.
5. Chantalat L, Jones ND, Korber F, Navaza J, Pavlovsky AG. 1995. The crystal structure of wild-type growth hormone at 2.5 A resolution. Protein Pept Lett 2:333-340.
6. Zamiri C, Groves MJ. 2005. Stabilization of soma-tropin by heparin. J Pharm Pharmacol 57:555-564.
7. Burke CJ, Volkin DB, Mach H, Middaugh CR. 1993. Effect of polyanions on the unfolding of acidic fibro-blast growth factor. Biochemistry 32:6419-6426.
8. Conrad HE. 1998. Heparin-binding proteins. San Diego, CA: Academic Press.
9. Jones LS, Yazzie B, Middaugh CR. 2004. Polyanions and the proteome. Mol Cell Proteomics 3:746-769.
10. Mach H, Volkin DB, Burke CJ, Middaugh CR, Linhardt RJ, Fromm JR, Loganathan D, Mattsson L. 1993. Nature of the interaction of heparin with acidic fibroblast growth factor. Biochemistry 32:5480-5489.
11. Maclean DS, Qian Q, Middaugh CR. 2002. Stabilization of proteins by low molecular weight multiions. J Pharm Sci 91:2220-2229.
12. Marquis-Omer D, Sanyal G, Volkin DB, Marcy AI, Chan HK, Ryan JA, Middaugh CR. 1991. Stabilization of the FK506 binding protein by ligand binding. Biochem Biophys Res Commun 179:741-748.
13. Volkin DB, Tsai PK, Dabora JM, Gress JO, Burke CJ, Linhardt RJ, Middaugh CR. 1993. Physical stabilization of acidic fibroblast growth factor by polyanions. Arch Biochem Biophys 300:30-41.
14. Volkin DB, Verticelli AM, Marfia KE, Burke CJ, Mach H, Middaugh CR. 1993. Sucralfate and soluble sucrose octasulfate bind and stabilize acidic fibroblast growth factor. Biochim Biophys Acta 1203:18-26.
15. Altincicek B, Shibamiya A, Trusheim H, Tzima E, Niepmann M, Linder D, Preissner KT, Kanse SM. 2006. A positively charged cluster in the epidermal growth factor-like domain of Factor VII-activating protease (FSAP) is essential for polyanion binding. Biochem J 394:687-692.
16. Hojima Y, Cochrane CG, Wiggins RC, Austen KF, Stevens RL. 1984. In vitro activation of the contact (Hageman factor) system of plasma by heparin and chondroitin sulfate E. Blood 63:1453-1459.
17. Freire E, Mayorga OL, Straume M. 1990. Isothermal titration calorimetry. Anal Chem 62:950A-959A.
18. Baerga-Ortiz A, Bergqvist S, Mandell JG, Komives EA. 2004. Two different proteins that compete for binding to thrombin have opposite kinetic and thermodynamic profiles. Protein Sci 13:166-176.
19. Carneiro FA, Bianconi ML, Weissmuller G, Stauffer F, Da Poian AT. 2002. Membrane recognition by vesicular stomatitis virus involves enthalpy-driven protein-lipid interactions. J Virol 76:3756-3764.
20. Parker MH, Brouillette CG, Prevelige PE, Jr. 2001. Kinetic and calorimetric evidence for two distinct scaffolding protein binding populations within the bacteriophage P22 procapsid. Biochemistry 40: 8962-8970.
21. Chattopadhyay A, Rukmini R. 1993. Restricted mobility of the sole tryptophan in membrane-bound melittin. FEBS Lett 335:341-344.
22. Demchenko AP. 2002. The red-edge effects: 30 years of exploration. Luminescence 17:19-42.
23. Ghose M, Mandal S, Roy D, Mandal RK, Basu G. 2001. Dielectric relaxation in a single tryptophan protein. FEBS Lett 509:337-340.
24. Guha S, Rawat SS, Chattopadhyay A, Bhattacharyya B. 1996. Tubulin conformation and dynamics: A red edge excitation shift study. Biochemistry 35:13426-13433.
25. Wintrode PL, Privalov PL. 1997. Energetics of target peptide recognition by calmodulin: A calorimetric study. J Mol Biol 266:1050-1062.
26. Sommer A, Rifkin DB. 1989. Interaction of heparin with human basic fibroblast growth factor: Protection of the angiogenic protein from proteolytic degradation by a glycosaminoglycan. J Cell Physiol 138:215-220.
27. Capila I, VanderNoot VA, Mealy TR, Seaton BA, Linhardt RJ. 1999. Interaction of heparin with annexin V. FEBS Lett 446:327-330.
28. Plotnikov AN, Hubbard SR, Schlessinger J, Mohammadi M. 2000. Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity. Cell 101:413-424.
29. Plotnikov AN, Schlessinger J, Hubbard SR, Mohammadi M. 1999. Structural basis for FGF receptor dimerization and activation. Cell 98:641-650.
30. Kuschert GS, Coulin F, Power CA, Proudfoot AE, Hubbard RE, Hoogewerf AJ, Wells TN. 1999. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry 38:12959-12968.
31. Proudfoot AE. 2006. The biological relevance of chemokine-proteoglycan interactions. Biochem Soc Trans 34:422-426.
32. Handel TM, Johnson Z, Crown SE, Lau EK, Proudfoot AE. 2005. Regulation of protein function by glycosaminoglycans - as exemplified by chemokines. Annu Rev Biochem 74:385-410.
33. Neshich G, Mancini AL, Yamagishi ME, Kuser PR, Fileto R, Pinto IP, Palandrani JF, Krauchenco JN, Baudet C, Montagner AJ, Higa RH. 2005. STING Report: Convenient web-based application for graphic and tabular presentations of protein sequence, structure and function descriptors from the STING database. Nucleic Acids Res 33:D269-D274.
34. Neshich G, Rocchia W, Mancini AL, Yamagishi ME, Kuser PR, Fileto R, Baudet C, Pinto IP, Montagner AJ, Palandrani JF, Krauchenco JN, Torres RC, Souza S, Togawa RC, Higa RH. 2004. JavaProtein Dossier: A novel web-based data visualization tool for comprehensive analysis of protein structure. Nucleic Acids Res 32:W595-W601.
35. Neshich G, Togawa RC, Mancini AL, Kuser PR, Yamagishi ME, Pappas G, Jr., Torres WV, Fonseca e Campos T, Ferreira LL, Luna FM, Oliveira AG, Miura RT, Inoue MK, Horita LG, de Souza DF, Dominiquini F, Alvaro A, Lima CS, Ogawa FO, Gomes GB, Palandrani JF, dos Santos GF, de Freitas EM, Mattiuz AE, Costa IC, de Almeida CL, Souza S, Baudet C, Higa RH. 2003. STING Millennium: A web-based suite of programs for comprehensive and simultaneous analysis of protein structure and sequence. Nucleic Acids Res 31:3386-3392.
36. de Vos AM, Ultsch M, Kossiakoff AA. 1992. Human growth hormone and extracellular domain of its receptor: Crystal structure of the complex. Science 255:306-312.
37. Chen C, Brinkworth R, Waters MJ. 1997. The role of receptor dimerization domain residues in growth hormone signaling. J Biol Chem 272: 5133-5140.
38. Kossiakoff AA. 1995. Structure of the growth hormone-receptor complex and mechanism of receptor signaling. J Nucl Med 36:14S-16S.
39. Behncken SN, Waters MJ. 1999. Molecular recognition events involved in the activation of the growth hormone receptor by growth hormone. J Mol Recognit 12:355-362.
40. Cunningham BC, Ultsch M, De Vos AM, Mulkerrin MG, Clauser KR, Wells JA. 1991. Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science 254:821-825.
41. Fuh G, Cunningham BC, Fukunaga R, Nagata S, Goeddel DV, Wells JA. 1992. Rational design of potent antagonists to the human growth hormone receptor. Science 256:1677-1680.
42. Kossiakoff AA. 2004. The structural basis for biological signaling, regulation, and specificity in the growth hormone-prolactin system of hormones and receptors. Adv Protein Chem 68:147-169.
43. Walsh ST, Sylvester JE, Kossiakoff AA. 2004. The high- and low-affinity receptor binding sites of growth hormone are allosterically coupled. Proc Natl Acad Sci USA 101:17078-17083.
44. Rowlinson SW, Behncken SN, Rowland JE, Clarkson RW, Strasburger CJ, Wu Z, Baumbach W, Waters MJ. 1998. Activation of chimeric and full-length growth hormone receptors by growth hormone receptor monoclonal antibodies. A specific conformational change may be required for full-length receptor signaling. J Biol Chem 273:5307-5314.
45. Jiang J, Wang X, He K, Li X, Chen C, Sayeski PP, Waters MJ, Frank SJ. 2004. A conformationally sensitive GHR [growth hormone (GH) receptor] antibody: impact on GH signaling and GHR proteolysis. Mol Endocrinol 18:2981-2996.